XML 34 R23.htm IDEA: XBRL DOCUMENT v3.25.3
Insider Trading Arrangements - Chris Morabito
3 Months Ended
Sep. 30, 2025
shares
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

During the third quarter of 2025, Chris Morabito, our Chief Medical Officer, terminated a Rule 10b5-1 trading arrangement for the sale of our common stock intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended, which was adopted on September 25, 2024. Pursuant to the plan, the aggregate number of options to be exercised, and the aggregate number of shares of common stock to be sold upon exercise of those options, was not to exceed 20,000.

Name Chris Morabito
Title Chief Medical Officer
Adoption Date September 25, 2024
Rule 10b5-1 Arrangement Terminated true
Termination Date During the third quarter of 2025
Aggregate Available 20,000